Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old

Cytotherapy

Volumn 16, Issue 3, 2014, Pages 406-411

  Motlló, Cristina ^a   Sancho, Juan Manuel ^a   Grífols, Joan Ramon ^b   Juncà, Jordi ^a   Morgades, Mireia ^a   Ester, Anna ^b   Rodríguez, Inés ^a   Vives, Susana ^a   Batlle, Montserrat ^a   Guardia, Ramon ^c   Ferrà, Christelle ^a   Gallardo, David ^a   Millá, Fuensanta ^a   Feliu, Evarist ^a   Ribera, Josep Maria ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Mobilization; Old related donors; Stem cell transplantation

Indexed keywords

MOBILIZATION; OLD RELATED DONORS; STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; YOUNG ADULT;

EID: 84893345579     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.08.005     Document Type: Article

References (22)

1. de Latour R.P., Labopin M., Cornelissen J., Vindelov L., Blaise D., Millpied N., et al. Equivalent outcome between older siblings and unrelated donors after reduced intensity hematopoietic stem cell transplantation for patients older than 50 years with acute myeloid leukemia in first complete remission: a report from the ALWP of EBMT. Blood (ASH Annual Meeting Abstract) 2012, 114. Abstract 961.
2. Servais S., Porcher R., Robin M., Xhaard A., Masson E., Larghero J., et al. Donor characteristics as pretransplant predictive factors of long-term outcome after allogeneic peripheral blood stem cell transplantation from HLA-matched related and unrelated donors in patients with hematologic malignancies. Blood (ASH Annual Meeting Abstract) 2012, 114. Abstract 2000.
3. Kollman C., Howe C.W.S., Anasetti C., Antin J.H., Davies S.M., Filipovich A.H., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001, 98:2043-2051.
4. Anderlini P., Donato M., Chan K.W., Huh Y.O., Gee A.P., Lauppe M.J., et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgastrim: the MD Anderson Cancer Center experience. Transfusion 1999, 39:555-560.
5. Favre G., Beksaç M., Bacigalupo A., Ruutu T., Nagler A., Gluckman E., et al. Differences between graft product and donor side effects following bone marrow or stem cell donation. Bone Marrow Transplant 2003, 32:873-880.
6. To L.B., Haylock D.N., Simmons P.J., Juttner C.A. The biology and clinical uses of blood stem cells. Blood 1997, 89:2233-2258.
7. Sutherland R., Anderson L., Keeney M., Nayar R., Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. Hematotherapy J 1996, 5:213-226.
8. Perez-Simon J.A., Caballero M.D., Corral M., Nieto M.J., Orfao A., Vazquez L., et al. Minimal number of circulating CD34+ cells to ensure success leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998, 38:385-391.
9. Przepiorka D., Weisdorf D., Martin P., Klingemann H.G., Beatty P., Hoes J., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
10. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2005, 11:945-955.
11. Kaplan G.L., Meier P. Nonparametric estimation from incomplete observations. JAm Statist Assoc 1958, 53:457-481.
12. Peto R., Pike M.C. Conservatism of the approximation sigma (O-E)2-E in the log rank test for survival data or tumor incidence data. Biometrics 1973, 29:579-584.
13. Gray R.J. Aclass of K-sample test for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
14. To L.B., Levesque J.P., Herbert K.E. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011, 118:4530-4540.
15. Buckner C.D., Clift R.A., Sanders J.E., Stewart P., Bensinger W.I., Doney K.C., et al. Marrow harvesting from normal donors. Blood 1984, 64:630-634.
16. Fischer J.C., Frick M., Wassmuth R., Platz A., Punzel M., Wernet P. Superior mobilization of hematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors. Br J Haematol 2005, 130:740-746.
17. Ings S.J., Balsa C., Leverett D., Mackinnon S., Linch D.C., Watts M.J. Peripheral blood stem cells yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Hematol 2006, 134:517-525.
18. Richa E.M., Kunnavakkam R., Godley L.A., Kline J., Odenike O., Larson R.A., et al. Influence of related donor age on outcomes after peripheral blood stem cell transplantation. Cytotherapy 2012, 14:707-715.
19. De la Rubia J., Arbona C., de Arriba F., del Cañizo C., Brunet S., Zamora C., et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002, 42:4-9.
20. Rinaldi C., Savignano C., Pasca S., Sperotto A., Patriarca F., Isola M., et al. Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. Transfusion 2012, 52:2387-2394.
21. Anderlini P., Przepiorka D., Seong C., Smith T.L., Huh Y.O., Lauppe J., et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997, 37:507-512.
22. Vasu S., Leitman S.F., Tisdale J.F., Hsieh M.M., Childs R.W., Barrett A., et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood 2008, 112:2092-2100.